Tech Company Financing Transactions

Celator Pharmaceuticals Funding Round

On 12/31/2011, Celator Pharmaceuticals raised $2.6 million in funding from Domain Associates, Quaker Partners, Thomas and McNerny & Partners.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

200 Princeton South Corporate Centre 180
Princeton, NJ 08628
USA

Phone

609-243-0123

Website

www.celatorpharma.com

Email Address

[email protected]

Overview

Celator biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes in cancer.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Scott Jackson

        

Chief Financial Officer

Fred Powell

        

Chief Medical Officer

Arthur Louie

        

President

Lawrence Mayer

        

VP - Regulatory Affairs

Lisa DeLuca

        

Browse more venture capital transactions:

Prev: 12/31/2011: SoloHealth venture capital transaction
Next: 12/31/2011: Rhythm Pharmaceuticals venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. All VC database entries reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary